Leaderboards/Head and Neck Cancer Studies

Head and Neck Cancer Studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Harriet Rumgay
Centre international de recherche sur le cancer
2
Laurel B. Darragh
University of Colorado Anschutz Medical Campus
3
Joris L. Vos
Memorial Sloan Kettering Cancer Center
4
Tianjiao Zhou
Shanghai Jiao Tong University
5
Ann‐Kristin Struckmeier
Universität Hamburg
6
Gizem Tanriver
Great Ormond Street Hospital
7
Shuang Huang
Zhejiang Cancer Hospital
8
Ye Guo
Shanghai East Hospital
9
Mackenzie Fijardo
University of Toronto
10
Daniel Bastías
Universidad Andrés Bello

Papers

1
Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis
The Lancet Oncology|2024
97 cit.
2
Global burden of head and neck cancers from 1990 to 2019
iScience|2024
78 cit.
3
The clinical manifestations and molecular pathogenesis of radiation fibrosis
EBioMedicine|2024
67 cit.
4
Publication in International Journal of Molecular Sciences (2024) [64 citations, W4392163221]
International Journal of Molecular Sciences|2024
64 cit.
5
Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs
Med|2024
53 cit.
6
Global trends and risk factors of laryngeal cancer: a systematic analysis for the Global Burden of Disease Study (1990–2021)
BMC Cancer|2025
23 cit.
7
Publication in Head & Neck (2024) [22 citations, W4392959714]
Head & Neck|2024
22 cit.
8
Publication in Clinical Oral Investigations (2024) [22 citations, W4394977085]
Clinical Oral Investigations|2024
22 cit.
9
Publication in Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (2024) [16 citations, W4390659845]
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2024
16 cit.
10
Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma
JCI Insight|2024
16 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Lin‐Quan Tang
Sun Yat-sen University
2
Gaorav P. Gupta
University of North Carolina at Chapel Hill
3
Xing Lv
Chinese Academy of Medical Sciences & Peking Union Medical College
4
Nosayaba Osazuwa‐Peters
Duke University
5
Vasu Divi
Palo Alto University
6
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
7
Sidharth V. Puram
Washington University in St. Louis
8
Ryan S. Jackson
Washington University in St. Louis
9
Steven M. Sperry
Vanderbilt University Medical Center
10
Ameya A. Jategaonkar
Barrow Neurological Institute

Papers

1
Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer
Cancer Discovery|2023
391 cit.
2
EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma
Cell Death and Differentiation|2022
150 cit.
3
MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis
Nature|2024
121 cit.
4
Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma
Nature Genetics|2023
107 cit.
5
Head‐to‐Head Comparison of ChatGPT Versus Google Search for Medical Knowledge Acquisition
Otolaryngology|2023
105 cit.
6
Changing Epidemiology of Oral Cavity Cancer in the United States
Otolaryngology|2022
97 cit.
7
Trends in Reasons for Human Papillomavirus Vaccine Hesitancy: 2010–2020
PEDIATRICS|2023
52 cit.
8
Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer
Human Vaccines & Immunotherapeutics|2022
37 cit.
9
Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years
Human Vaccines & Immunotherapeutics|2024
35 cit.
10
Single-cell RNA sequencing identifies a paracrine interaction that may drive oncogenic notch signaling in human adenoid cystic carcinoma
Cell Reports|2022
25 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Maura L. Gillison
The University of Texas MD Anderson Cancer Center
2
Jun Ma
Shanghai Institute of Technology
3
Everett E. Vokes
University of Chicago
4
Jean Bourhis
University of Lausanne
5
Silvia Franceschi
Centro di Riferimento Oncologico
6
William M. Mendenhall
Florida College
7
Jatin P. Shah
Memorial Sloan Kettering Cancer Center
8
David Sidransky
University of Baltimore
9
Jens Overgaard
Aarhus University
10
Barbara Burtness
Yale University

Papers

1
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
New England Journal of Medicine|2010
6.5k cit.
2
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
New England Journal of Medicine|2016
5.1k cit.
3
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Journal of Clinical Oncology|2011
3.6k cit.
4
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
JNCI Journal of the National Cancer Institute|2000
3.1k cit.
5
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Radiotherapy and Oncology|2009
3k cit.
6
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
New England Journal of Medicine|2007
2.7k cit.
7
Worldwide burden of cancer attributable to HPV by site, country and HPV type
International Journal of Cancer|2017
2.3k cit.
8
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
Nature Medicine|1995
2k cit.
9
Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual
CA A Cancer Journal for Clinicians|2017
1.7k cit.
10
Global burden of cancers attributable to infections in 2012: a synthetic analysis
The Lancet Global Health|2016
1.6k cit.

Reagents for Head and Neck Cancer Studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

Merlin/Ezrin/Radixin/Moesin (D1P8I) Rabbit Monoclonal Antibody

#23292$161,351
View Evidence →
Agilent/Dako

Cytokeratin 19

#M0888
View Evidence →
Cell Signaling TechnologyEvidence 66

His-Tag (D3I1O) Rabbit Monoclonal Antibody (Alexa Fluor® 555 Conjugate)

#20664$465
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

MLXIP/MondoA (F8A8L) Rabbit Monoclonal Antibody

Cited in 13 papers
#72133$161,376
View Evidence →
Agilent/Dako

p53 Tumor Suppressor Protein

Cited in 5 papers
#M7001
View Evidence →
Cell Signaling TechnologyEvidence 65

PathScan® RP Phospho-ULK1 (Ser638) Sandwich ELISA Kit

#30954$67,830,490
View Evidence →